Search CommunityWalk:


Artecel inc.

4800 Montgomery Lane, Suite 800
Bethesda, MD, USA

Category: Biomaterials & Tissue Regeneration

Used in the following map:

Maryland Biotech Industry Map

Artecel inc. is a provider of adipose-derived stem cell (ASC) banking services and therapeutic products derived from ASCs. It is focused on autologous applications in cosmetic surgery and hematopoietic support. The company was founded in 2000 as Artecel Sciences and later in April, 2003 Capital Corp. has acquired the assets of Artecel Sciences and changed its name to Artecel.

Artecel develops products and services in two major lines of business: cell banking of ASCs and therapeutic products made from ASCs for orthopaedic and dental applications, and soft tissue and cosmetic applications. The company also develops certain applications of ASCs in high-value drug discovery and research tools to be used in liver toxicity testing. It applies its products in four clinical applications: (1) soft tissue cosmesis, (2) hematopoietic support during bone marrow transplantation, (3) repair of bone, and (4) repair of cartilage.

Artecel's Cell banking is an emerging treatment strategy premised on the ready availability of an individual's viable, multi-lineage, autologous cells for the repair of diseased or injured tissues. The company's first generation ASC products are autologous (i.e., made from an individual patient's own cells, with minimal manipulation). Its second generation products are allogeneic (i.e., made with cells obtained from a donor, grown to large numbers in cell culture and stored in inventory, and delivered to other patients).

Artecel has alliances with The National Institutes of Health, and United States Department of Health and Human Services.